Health product recall

JAMP Venlafaxine XR 37.5 mg capsules; Mislabelling

Last updated

Summary

Product
JAMP Venlafaxine XR 37.5 mg capsules
Issue
Health products - Labelling
What to do
  • Check the capsules in your pharmacy bottle of JAMP Venlafaxine XR 37.5 mg capsules to make sure it contains 37.5 mg capsules (grey / pink in colour) and not 150 mg capsules (caramel in colour). If it contains 150 mg capsules, or if you are unsure, return it to your pharmacy as soon as possible. Your pharmacist will check it and provide a replacement with the correct capsules, if needed.
  • Contact your health care professional if you have taken the wrong dose of your medication. Seek medical attention immediately if you experience any serious side effects from Venlafaxine XR, which may include allergic reactions, gastrointestinal bleeding, seizures, heart rhythm problems, blurred vision, eye pain, or severe headache.

Affected products

Brand Product Name Market Authorization Dosage Form Strength Lot number
Jamp Pharma Venlafaxine 37.5 mg capsule DIN 02516535 Capsule (extended release) Venlafaxine hydrochloride 37.5 mg PTC5140A

Issue

An incorrect label (Venlafaxine XR 37.5 mg) is attached to some units of the affected lot which contains: Venlafaxine XR 150 mg.

What you should do

  • Check the capsules in your pharmacy bottle of JAMP Venlafaxine XR 37.5 mg capsules to make sure it contains 37.5 mg capsules (grey / pink in colour) and not 150 mg capsules (caramel in colour). If you are unsure, contact your pharmacist to check if your bottle contains the correct capsules.
  • If you see incorrect capsules, stop taking the medication and contact your pharmacy immediately for a replacement product. Return the affected product to your pharmacy for proper disposal.
  • Contact your health care professional if you have taken the wrong dose of your medication. Seek medical attention immediately if you experience any serious side effects from Venlafaxine XR, which may include allergic reactions, gastrointestinal bleeding, seizures, heart rhythm problems, blurred vision, eye pain, or severe headache.
  • Contact JAMP Pharma Corporation by email at alewicki@jamppharma.com if you have questions about this recall.
  • Report any health product-related side effects or complaints to Health Canada.

Additional information

Background

Depth of recall: Retailers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Jamp Pharma
1310 Nobel, 
Boucherville Québec J4B 5H3 Canada

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-73865